4//SEC Filing
Friedland Jeffrey 4
Accession 0001214659-18-001508
CIK 0001625288other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 3:31 PM ET
Size
11.2 KB
Accession
0001214659-18-001508
Insider Transaction Report
Form 4
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
- Small Acquisition
Common Stock
2018-01-16$0.25/sh+20,800$5,200→ 228,800 total(indirect: By LLC) - Exercise of In-Money
Class A Warrants (right to buy)
2018-01-16−20,800→ 0 total(indirect: By LLC)Exercise: $0.25From: 2017-11-29Exp: 2018-01-31→ Common Stock (20,800 underlying)
Holdings
- 2,000,000
Common Stock
- 24,000,000(indirect: By Intiva USA Inc.)
Common Stock
- 20,800(indirect: By LLC)
Class B Warrants (right to buy)
Exercise: $0.38From: 2017-11-29Exp: 2018-05-07→ Common Stock (20,800 underlying) - 20,800(indirect: By LLC)
Class C Warrants (right to buy)
Exercise: $0.50From: 2017-11-29Exp: 2018-07-14→ Common Stock (20,800 underlying)
Footnotes (1)
- [F1]Acquired in exchange for all of Lane 6552 LLC's Class A warrants of Intiva BioPharma Inc.
Documents
Issuer
Intiva BioPharma Inc.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001579962
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 3:31 PM ET
- Size
- 11.2 KB